NIH Discovers Why GLP-1 Weight Loss Drugs Plateau and How to Fix It
New NIH research reveals the brain-cell signaling mechanism behind GLP-1 drug plateaus and a potential way to extend their effects.
20 articles
New NIH research reveals the brain-cell signaling mechanism behind GLP-1 drug plateaus and a potential way to extend their effects.
UC San Diego study shows one week of intensive meditation produces measurable brain changes and enhanced neuroplasticity comparable to psychedelic effects.
UC Berkeley researchers discovered brain circuits linking deep sleep to growth hormone release, revealing how sleep builds muscle and burns fat.
A new tool that boosts mitochondrial activity in neurons restored memory in dementia mice, suggesting energy failure drives Alzheimer's symptoms.
A large clinical trial finds baduanjin, a gentle 800-year-old Chinese practice, lowers blood pressure comparably to medication and brisk walking.
New research reveals GLP-1 drugs like Ozempic significantly reduce depression, anxiety, and substance use disorders alongside weight management.
Clinical trial shows solriamfetol significantly improves alertness and performance in workers who start before sunrise.
Blocking the protein PTP1B boosted memory and cleared brain plaque in mice, with potential links to diabetes and obesity treatment.
Norwegian researchers say short bursts of high-intensity effort just 4.5 minutes daily dramatically improve cardiovascular fitness and lifespan.
A study of 100,000 people found semaglutide users had 44% lower depression risk and 42% fewer psychiatric hospitalizations.
New research identifies FTL1 protein as key driver of brain aging. Reducing it restored memory and neural connections in mice.
New research reveals depression may stem from cellular energy imbalances, offering hope for earlier diagnosis and targeted treatments.
Declining Menin in the hypothalamus drives inflammation and aging. Restoring it reversed decline; D-serine amino acid improved cognition in mice.
Comprehensive analysis reveals whole dietary patterns, not individual supplements, show strongest links to reduced depression in adolescents.
A Rutgers study finds GLP-1 users show dramatically weaker links between impulsivity, alcohol use, and violent behavior.
Scientists discover harmful bacterial sugars in the gut trigger immune attacks that damage the brain in ALS and dementia patients.
Recent NIA findings spotlight lifestyle factors cutting Alzheimer's risk by 60%, calorie restriction slowing aging, and a gene regulating plaque toxicity.
New study of 96,000 people shows brief bursts of intense activity dramatically reduce risks of heart disease, dementia, and diabetes.
New mouse research finds the trendy D+Q senolytic combo severely damages myelin, raising red flags for longevity self-experimenters.
New research reveals that brain cells active after workouts—not just during—are key to building endurance over time.